Pale Fire Capital SE Acquires New Position in IGM Bioscience

Pale Fire Capital SE bought a new stake in IGM Biosciences, Inc. (NASDAQ:IGMS – Free Report) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 12,601 shares of the company’s stock, valued at approximately $105,000. Several other hedge funds and […]

Related Keywords

Blackrock , Nova Scotia , Canada , Stifel Nicolaus , Bruce Keyt , Nasdaq , Pricet Rowe Associates Inc , Biosciences Inc , Morgan Stanley , Blackrock Inc , Artal Group , Securities Exchange Commission , Royal Bank , Exchange Commission , Pale Fire Capital , Free Report , Advisors Lp Baker , Visit Holdingschannel , Digm Biosciences , Nasdaq Igms , Igms , Medical , Sec Filings , 13f , Hedge Fund Holdings , Institutional Investor Holdings ,